Asterios Karagiannis

Aristotle University of Thessaloniki — Greece

Medicine · Health Sciences

49h-index9.7kcitations369works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lipoproteins and Cardiovascular Health(96), Blood Pressure and Hypertension Studies(56), Diabetes Treatment and Management(55), Diabetes, Cardiovascular Risks, and Lipoproteins(50), Liver Disease Diagnosis and Treatment(50)

Publications369 total

The Associations between Kidney Function and Sexual Dysfunction among Males and Females with Type 2 Diabetes Mellitus
Medicina·2023· 6 citedOpen Access
The role of asymmetric dimethylarginine in endothelial dysfunction and abnormal nitric oxide metabolism in systemic sclerosis: results from a pilot study
Clinical Rheumatology·2022· 5 cited
Renal effects of sodium-glucose co-transporter-2 inhibitors in patients with heart failure with reduced or preserved ejection fraction
Nefrología (English Edition)·2022Open Access
Effect of Empagliflozin and Dapagliflozin on Ambulatory Arterial Stiffness in Patients with Type 2 Diabetes Mellitus and Cardiovascular Co-Morbidities: A Prospective, Observational Study
Medicina·2022· 7 citedOpen Access
Meta-Analysis Evaluating the Cardiovascular Efficacy of Sodium-Glucose Co-Transporter-2 Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction According to Baseline Anemia
The American Journal of Cardiology·2022
Sodium-glucose co-transporter-2 inhibitor mediated cardio-protection: does increase of hematocrit finally matter? Sub-analysis of a prospective, observational study
Archives of Medical Science - Atherosclerotic Diseases·2022· 1 citedOpen Access
Right ventricular performance in patients with heart failure with mildly reduced ejection fraction: the forgotten ventricle
The International Journal of Cardiovascular Imaging·2022· 3 cited
Effect of sodium-glucose co-transporter-2 inhibitors on right ventricular function in patients with type 2 diabetes mellitus: A pilot study
Kardiologia Polska·2022· 3 citedOpen Access
Effect of sodium-glucose co-transporter-2 inhibitors on arterial stiffness: A systematic review and meta-analysis of randomized controlled trials
Vascular Medicine·2022· 26 cited
BENEFICIAL EFFECT OF SODIUM-GLUCOSE CO-TRANSPORTER-2 INHIBITORS ON RIGHT VENTRICULAR SYSTOLIC FUNCTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A PILOT, OBSERVATIONAL STUDY
Journal of Hypertension·2022
GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS DO NOT DECREASE THE RISK FOR CORONARY REVASCULARIZATION IN PATIENTS WITH TYPE 2 DIABETES: A META-ANALYSIS OF CARDIOVASCULAR OUTCOME TRIALS
Journal of Hypertension·2022
META-ANALYSIS OF THE EFFECT OF DUAL GIP AND GLP-1 RECEPTOR AGONISTS ON BLOOD PRESSURE LEVELS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Journal of Hypertension·2022· 2 cited
MAJOR ADVERSE EVENTS WITH THE USE OF FINERENONE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A META-ANALYSIS OF CARDIOVASCULAR OUTCOME TRIALS
Journal of Hypertension·2022· 2 cited
“WHICH ONE SHOULD I CHOOSE, A GLP-1RA OR A SGLT2 INHIBITOR? OR MAYBE BOTH?’’. A POOLED ANALYSIS OF CARDIOVASCULAR OUTCOME TRIALS
Journal of Hypertension·2022
Meta-Analysis Assessing the Cardiovascular Efficacy of Sodium-Glucose Co-Transporter-2 Inhibitors in Patients With Chronic Obstructive Pulmonary Disease
The American Journal of Cardiology·2022· 1 cited
Meta-Analysis Assessing the Impact of Previous Heart Failure and Chronic Kidney Disease on the Cardiovascular Efficacy of Glucagon-Like Peptide-1 Receptor Agonists
The American Journal of Cardiology·2022· 1 cited
Meta-Analysis of Randomized Controlled Trials Evaluating the Effect of Dual Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 Receptor Agonists on Blood Pressure Levels in Patients With Type 2 Diabetes Mellitus
The American Journal of Cardiology·2021· 5 cited
“Which one should I choose, a glucagon-like peptide-1 receptor agonist or a sodium−glucose cotransporter 2 inhibitor? Or maybe both?”
European Journal of Internal Medicine·2021· 1 cited
Renal effects of sodium-glucose co-transporter-2 inhibitors in patients with heart failure with reduced or preserved ejection fraction
Nefrología·2021Open Access
Meta-Analysis Addressing the Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Flow-Mediated Dilation in Patients With Type 2 Diabetes Mellitus
The American Journal of Cardiology·2021· 5 cited
page 1 of 19Next →

Frequent Co-authors

Vasilios G. Athyros(43), Dimitri P. Mikhailidis(25), Κωνσταντίνος Τζιόμαλος(24), Niki Katsiki(16), Panagiotis Anagnostis(13), Anna I. Kakafika(13), Michael Doumas(8), Dimitri P. Mikhailidis(8), Κonstantinos Imprialos(6), Moses Elisaf(6), Evangelos Liberopoulos(6), Emmanuel S. Ganotakis(5), Konstantinos Stavropoulos(4), Athanasios A. Papageorgiou(4), Pantelis Sarafidis(4), Thomas Gossios(3), Theodora Griva(3), Efstathios D. Pagourelias(3), Όλγα Γιουλεμέ(3), Απόστολος Τσάπας(3)